Summary
A patient with HBsAg-positive subacute hepatitis who presented a progressively deteriorating clinical condition was treated with azathioprine (100 mg/day) for eight months. Although the clinical symptoms disappeared and the biochemical abnormalities decreased, the disease nevertheless progressed to chronic active hepatitis. Moreover, azathioprine favoured hepatitis B virus replication since titers of HBsAg, HBeAg and Dane-particle-associated coreantigen, as detected by radioimmunoassay, increased during treatment. In all, this drug was only of moderate use to our patient.
Zusammenfassung
Ein Patient mit HBsAg-positiver, subakuter Hepatitis und progressiver klinischer Verschlechterung wurde acht Monate lang mit 100 mg/Tag Azathioprin behandelt. Obwohl die klinischen Symptome verschwanden und sich die biochemischen Parameter besserten, ging die Erkrankung in eine chronisch aktive Hepatitis über. Daneben begünstigte Azathioprin die Hepatitis-B-Virus-Replikation, denn die im Radioimmunoassay bestimmten Titer von HBsAg, HBeAg und Dane-Partikel-assoziiertem Core Antigen stiegen unter der Behandlung an. Insgesamt war das Medikament nur von mäßigem Nutzen für den Patienten.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literature
Ware, A. J., Eigenbrodt, E. H., Combes, B. Prognostic significance of subacute hepatic necrosis in acute hepatitis. Gastroenterology 68 (1975) 519–524.
Boyer, J. L., Klatskin, G. Pattern on necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatitis necrosis). N. Engl. J. Med. 283 (1970) 1063–1071.
Horney, J. T., Galambos, J. T. The liver during and after fulminant hepatitis. Gastroenterology 73 (1977) 639–645.
Gregory, P. B., Knauer, C. M., Kempson, R. L., Miller, R. Steroid therapy in severe viral hepatitis. A double-blind randomized trial of methylprednisolone versus placebo. N. Engl. J. Med. 294 (1976) 681–687.
Athol, A. W., Jennifer, A. C., James, S., Larry, E. G., Edwin, H. E., Combes, B. A prospective trial of steroid therapy in severe viral hepatitis. The prognostic significance of bridging necrosis. Gastroenterology 80 (1981) 219–224.
Sagnelli, E., Manzillo, G., Maio, G., Pasquale, G., Felaco, F. M., Filippini, P., Izzo, C. M., Piccinino, F. Serum levels of hepatitis B surface and core antigen during immunosuppressive treatment of HBsAg positive chronic active hepatitis. Lancet II (1980) 395–397.
Purcell, R. H., Gerin, J. L., Almeida, J. B., Holland, P. V. Radioimmunoassy for the detection of the core of the Dane particles and antibody. Intervirology 2 (1974) 231–243.
Sagnelli, E., Vernace, S. J., Paronetto, F. Dane particle associated hepatitis B core antigen in patients with HBsAg positive chronic hepatitis. Gastroenterology 75 (1978) 864–868.
Fields, H. A., Bradley, D. W., Davis, C. L., Murphy, B. L., Shable, C. A., Maynard, J. E. Radioimmunoassay for the detection of hepatitis B antigen (HBeAg) and antibody (anti-HBe). J. Immunol. 121 (1978) 930–935.
Miyakawa, Y., Tsuda, F., Akahane, Y., Mayumi, M. Application of microtiter solid-phase radioimmunoassay to the determination of hepatitis B e antigen. Vox Sang. 36 (1979) 307–311.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sagnelli, F., Felaco, F.M., Pasquale, G. et al. Azathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosis. Infection 11, 31–32 (1983). https://doi.org/10.1007/BF01651354
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01651354